MJ Millan, Y Agid, M Brüne, ET Bullmore… - Nature reviews Drug …, 2012 - nature.com
Studies of psychiatric disorders have traditionally focused on emotional symptoms such as depression, anxiety and hallucinations. However, poorly controlled cognitive deficits are …
Veterinary Pharmacology and Therapeutics, Tenth Edition is a fully updated and revised version of the gold-standard reference on the use of drug therapy in all major veterinary …
A Pertovaara - Progress in neurobiology, 2006 - Elsevier
Norepinephrine is involved in intrinsic control of pain. Main sources of norepinephrine are sympathetic nerves peripherally and noradrenergic brainstem nuclei A1–A7 centrally …
S Ayub, S Parnia, K Poddar, AK Bachu, A Sullivan… - Cureus, 2023 - ncbi.nlm.nih.gov
Introduction and objectives: The opioid overdose epidemic is exacerbated by the emergence of Xylazine as an illicit drug adulterant. Xylazine, a veterinary sedative, can …
Given the brain's uniquely high cell density and tissue oxygen levels bordering on hypoxia, the ability to rapidly and precisely match blood flow to constantly changing patterns in neural …
L Hickey, Y Li, SJ Fyson, TC Watson… - Journal of …, 2014 - Soc Neuroscience
Pontospinal noradrenergic neurons are thought to form part of a descending endogenous analgesic system that exerts inhibitory influences on spinal nociception. Using optogenetic …
A Pitkänen - Epilepsia, 2010 - Wiley Online Library
Prevention of epileptogenesis is an unmet need in medicine. During the last 3 years, however, several preclinical studies have demonstrated remarkable favorable effects of …
S Choi, MR Irwin, MR Noya, Y Shaham… - …, 2024 - nature.com
Xylazine, a veterinary tranquillizer known by drug users as “Tranq”, is being increasingly detected in people who overdose on opioid drugs, indicating enhanced health risk of …
Rationale Deficient response inhibition is a prominent feature of many pathological conditions characterised by impulsive and compulsive behaviour. Clinically effective doses …